nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiretroviral therapy: no increase in risk of coronary atherosclerosis
|
|
|
2002 |
919 |
1 |
p. 4 |
artikel |
2 |
Bimatoprost interaction
|
|
|
2002 |
919 |
1 |
p. 5 |
artikel |
3 |
Bleomycin/cisplatin/vincristine
|
|
|
2002 |
919 |
1 |
p. 5 |
artikel |
4 |
Botulinum toxin A `safe' for treatment of anal disorders
|
|
|
2002 |
919 |
1 |
p. 4-5 |
artikel |
5 |
Cetirizine
|
|
|
2002 |
919 |
1 |
p. 5-6 |
artikel |
6 |
Citalopram
|
|
|
2002 |
919 |
1 |
p. 6 |
artikel |
7 |
Depot medroxyprogesterone increases risk of cardiovascular disease?
|
|
|
2002 |
919 |
1 |
p. 3 |
artikel |
8 |
Dopamine administration: increased risk of delirium
|
|
|
2002 |
919 |
1 |
p. 3 |
artikel |
9 |
Famotidine
|
|
|
2002 |
919 |
1 |
p. 6 |
artikel |
10 |
Flutamide
|
|
|
2002 |
919 |
1 |
p. 6 |
artikel |
11 |
G-CSF: increased risk of myelodysplastic syndrome?
|
|
|
2002 |
919 |
1 |
p. 3 |
artikel |
12 |
Gemcitabine
|
|
|
2002 |
919 |
1 |
p. 6-7 |
artikel |
13 |
Gemcitabine: possible interaction with anticoagulants
|
|
|
2002 |
919 |
1 |
p. 2 |
artikel |
14 |
Ibuprofen
|
|
|
2002 |
919 |
1 |
p. 7 |
artikel |
15 |
Interferon-α-2b
|
|
|
2002 |
919 |
1 |
p. 8 |
artikel |
16 |
Interferon-α-2b
|
|
|
2002 |
919 |
1 |
p. 7-8 |
artikel |
17 |
Interferon-α/interferon-α-2b
|
|
|
2002 |
919 |
1 |
p. 7 |
artikel |
18 |
Itraconazole interaction
|
|
|
2002 |
919 |
1 |
p. 8 |
artikel |
19 |
Itraconazole interaction
|
|
|
2002 |
919 |
1 |
p. 8 |
artikel |
20 |
Lamotrigine
|
|
|
2002 |
919 |
1 |
p. 8-9 |
artikel |
21 |
Lidocaine/epinephrine
|
|
|
2002 |
919 |
1 |
p. 9 |
artikel |
22 |
Magnesium sulfate/ritodrine
|
|
|
2002 |
919 |
1 |
p. 9 |
artikel |
23 |
Methotrexate
|
|
|
2002 |
919 |
1 |
p. 9 |
artikel |
24 |
Nitrous oxide
|
|
|
2002 |
919 |
1 |
p. 9 |
artikel |
25 |
No increased risk of VTE with antipsychotics or antidepressants
|
|
|
2002 |
919 |
1 |
p. 4 |
artikel |
26 |
Paclitaxel
|
|
|
2002 |
919 |
1 |
p. 9-10 |
artikel |
27 |
Paroxetine
|
|
|
2002 |
919 |
1 |
p. 10 |
artikel |
28 |
PIs associated with hyperlipidaemia in children
|
|
|
2002 |
919 |
1 |
p. 2 |
artikel |
29 |
Propofol
|
|
|
2002 |
919 |
1 |
p. 10 |
artikel |
30 |
Protease inhibitors: no increase in sexual dysfunction
|
|
|
2002 |
919 |
1 |
p. 3 |
artikel |
31 |
Risperidone
|
|
|
2002 |
919 |
1 |
p. 10 |
artikel |
32 |
Rofecoxib
|
|
|
2002 |
919 |
1 |
p. 10 |
artikel |
33 |
Ticlopidine
|
|
|
2002 |
919 |
1 |
p. 11 |
artikel |
34 |
Trihexyphenidyl/zuclopenthixol withdrawal
|
|
|
2002 |
919 |
1 |
p. 11 |
artikel |
35 |
Vigabatrin: visual field constriction in paediatric patients
|
|
|
2002 |
919 |
1 |
p. 4 |
artikel |
36 |
Wyeth updates HRT product labels to reflect WHI findings
|
|
|
2002 |
919 |
1 |
p. 2 |
artikel |
37 |
Ziprasidone
|
|
|
2002 |
919 |
1 |
p. 12 |
artikel |
38 |
Ziprasidone
|
|
|
2002 |
919 |
1 |
p. 11 |
artikel |
39 |
Ziprasidone
|
|
|
2002 |
919 |
1 |
p. 11 |
artikel |